Bzbs
Bzbs has been studied in 2 papers since 2025: none in people yet, 1 in animals, 1 review. The research so far is in animals. The newest paper, Feb 21, 2025: “Senescent alveolar type II epithelial cells-secreted GDF15 promotes silicosis progression via interfering intercellular communication”.
2 papers study it1 findingUpdated
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funder: National Natural Science Foundation of China
- Animals1
What did studies of bzbs find?
1Studies of bzbs measured one outcome, pulmonary fibrosis.
Pulmonary fibrosis
downin A. model1
1 study
Pulmonary fibrosis
downin A. model1
Bzbs decrease pulmonary fibrosis in A. model.
“lipid nanoparticles targeting GDF15 or cell senescence inhibitor NMN and BZBS showed efficient anti-fibrotic effects in vivo.”
Animals
Ecotoxicology and environmental safety
Latest
Ecotoxicology and Environmental Safety
Senescent alveolar type II epithelial cells-secreted GDF15 promotes silicosis progression via interfering intercellular communication
Experiments in animalsInterventions